[EN] AGENTS FOR TREATING NEURODEGENERATIVE DISORDERS<br/>[FR] AGENTS POUR LE TRAITEMENT DE TROUBLES NEURODÉGÉNÉRATIFS
申请人:CRO CONSULTING LTD
公开号:WO2013111118A2
公开(公告)日:2013-08-01
The present invention relates to compounds of formula I, use of these compounds to treat mental and neurological disorders, especially depressions and psychoses of different etiology.. The compounds provided for the treatment of mental and neurological disorders are presented by a general formula I: wherein R, R', Y are as defined in specification or pharmaceutically acceptable salts thereof, solvates thereof such as hydrates, and pharmaceutical compositions containing such compounds.
Base-Mediated One-Pot Synthesis of Aliphatic Diazirines for Photoaffinity Labeling
Aliphatic diazirines have been widely used as prominent photophores for photoaffinitylabeling owing to their relatively small size which can reduce the steric effect on the natural interaction between ligands and proteins. Based on our continuous efforts to develop efficient methods for the synthesis of aliphatic diazirines, we present here a comprehensive study about base-mediated one-pot synthesis